Search

Your search keyword '"Procopio, Giuseppe"' showing total 1,245 results
Start Over Author "Procopio, Giuseppe"
1,245 results on '"Procopio, Giuseppe"'

1. On the ergodicity breaking in well-behaved Generalized Langevin Equations

Author

Procopio, Giuseppe, Pezzotti, Chiara, and Giona, Massimiliano

Subjects
Condensed Matter - Statistical Mechanics
Abstract

The phenomenon of ergodicity breaking of stochastic dynamics governed by Generalized Langevin Equations (GLE) in the presence of well-behaved exponentially decaying dissipative memory kernels, recently investigated by many authors (Phys. Rev. E {\bf 83} 062102 2011; Phys. Rev. E {\bf 98} 062140 2018; Eur. Phys. J. B {\bf 93} 184 2020), finds, in the dynamic theory of GLE, its simple and natural explanation, related to the concept of dissipative stability. It is shown that the occurrence of ergodicity breakdown for well-behaved dissipative kernels falls, in general, ouside the region of stochastic realizability, and therefore it cannot be observed in physical systems.

Published
2024

2. Dynamic fluctuation-dissipation theory for Generalized Langevin Equations: constructive constraints, stability and realizability

Author

Giona, Massimiliano, Procopio, Giuseppe, and Pezzotti, Chiara

Subjects
Condensed Matter - Statistical Mechanics
Abstract

Using the initial-value formulation, a dynamic theory for systems evolving according to a Generalized Langevin Equation is developed, providing more restrictive conditions on the existence of equilibrium behavior and its fluctuation-dissipation implications. For systems fulfilling the property of local realizability, that for all the practical purposes corresponds to the postulate of the existence of a Markovian embedding, physical constraints, expressed in the form of dissipative stability and stochastic realizability are derived. If these two properties are met, Kubo theory is constructively recovered, while if one of these conditions is violated a thermodynamic equilibrium behavior does not exist (and this occurs also for `` well-behaved dissipative systems'' according to the classical Kubo theory), with significant implications in the linear response theory.

Published
2024

3. On the theory of body motion in confined Stokesian fluids

Author

Procopio, Giuseppe and Giona, Massimiliano

Subjects
Physics - Fluid Dynamics
Abstract

We propose a theoretical method to decompose the solution of a Stokes flow past a body immersed in a confined fluid in two simpler problems, related separately to the two geometrical elements of these systems: (i) the body immersed in the unbounded fluid (represented by its Fax\'en operators), and (ii) the domain of the confinement (represented by its Stokesian multipoles). Specifically, by using a reflection method, and assuming linear and reciprocal boundary conditions \citep{procopio-giona_pof}, we provide the expression for the velocity field, the forces, torques and higher-order moments acting on the body in terms of: (i) the volume moments of the body in the unbounded ambient flow; (ii) the multipoles in the domain of the confinement; (iii) the collection of all the volumetric moments on the body immersed in all the regular parts of the multipoles considered as ambient flows. A detailed convergence analysis of the reflection method is developed. In the light of practical applications, we estimate the truncation error committed by considering only the lower order moments (thus truncating the matrices) and the errors associated with the approximated expressions available in the literature for force and torques. We apply the theoretical results to the archetypal hydrodynamic system of a sphere with Navier-slip boundary conditions near a plane wall with no-slip boundary conditions, to determine forces and torques on a translating and rotating sphere as a function of the slip length and of the distance of the sphere from the plane. The hydromechanics of a spheroid is also addressed.

Published
2023

4. Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study

Author

Messina, Carlo, Catalano, Martina, Roviello, Giandomenico, Gandini, Annalice, Maruzzo, Marco, De Giorgi, Ugo, Pedrazzoli, Paolo, Sbrana, Andrea, Zucal, Paolo Andrea, Masini, Cristina, Naglieri, Emanuele, Procopio, Giuseppe, Milella, Michele, Catalano, Fabio, Fratino, Lucia, Pipitone, Stefania, Ricotta, Riccardo, Panni, Stefano, Mollica, Veronica, Soraru, Mariella, Prati, Veronica, Atzori, Francesco, Di Napoli, Marilena, Messina, Marco, Morelli, Franco, Prati, Giuseppe, Nole, Franco, Malgeri, Andrea, Tudini, Marianna, Vignani, Francesca, Cavo, Alessia, Signori, Alessio, Banna, Giuseppe Luigi, Rescigno, Pasquale, Buti, Sebastiano, Rebuzzi, Sara Elena, and Fornarini, Giuseppe

Published
2024
Full Text
View/download PDF

7. On the Hinch-Kim dualism between singularity and Fax\'en operators in the hydromechanics of arbitrary bodies in Stokes flows

Author

Procopio, Giuseppe and Giona, Massimiliano

Subjects
Physics - Fluid Dynamics
Abstract

We generalize the multipole expansion and the structure of the Fax\'en operator in Stokes flows obtained for bodies with no-slip to generic boundary conditions, addressing the assumptions under which this generalization is conceivable. We show that a disturbance field generated by a body immersed in an ambient flow can be expressed as a multipole expansion the coefficients of which are the moments of the volume forces, independently on the boundary conditions. We find that the dualism between the operator giving the disturbance field of an $n$-th order ambient flow and the $n$-th order Fax\'en operator, referred to as the Hinch-Kim dualism, holds only if the boundary conditions satisfy a property that we call Boundary-Condition reciprocity (BC-reciprocity). If this property is fulfilled, the Fax\'en operators can be expressed in terms of the $(m,n)$-th order geometrical moments of the volume forces (defined in the article). In addition, it is shown that in these cases, the hydromechanics of the fluid-body system is completely determined by the entire set of the Fax\'en operators. Finally, classical boundary conditions of hydrodynamic practice are investigated in the light of this property: boundary conditions for rigid bodies, Newtonian drops at the mechanical equilibrium, porous bodies modeled by the Brinkman equations are BC-reciprocal, while deforming linear elastic bodies, deforming Newtonian drops, non-Newtonian drops and porous bodies modeled by the Darcy equations do not have this property. For Navier-slip boundary conditions on a rigid body, we find the analytical expression for low order Fax\'en operators.

Published
2023

8. Stochastic hydrodynamic velocity field and the representation of Langevin equations

Author

Giona, Massimiliano, Cocco, Davide, Procopio, Giuseppe, Cairoli, Andrea, and Klages, Rainer

Subjects
Condensed Matter - Statistical Mechanics
Abstract

The fluctuation-dissipation theorem, in the Kubo original formulation, is based on the decomposition of the thermal agitation forces into a dissipative contribution and a stochastically fluctuating term. This decomposition can be avoided by introducing a stochastic velocity field, with correlation properties deriving from linear response theory. Here, we adopt this field as the comprehensive hydrodynamic/fluctuational driver of the kinematic equations of motion. With this description, we show that the Langevin equations for a Brownian particle interacting with a solvent fluid become particularly simple and can be applied even in those cases in which the classical approach, based on the concept of a stochastic thermal force, displays intrinsic difficulties e.g., in the presence of the Basset force. We show that a convenient way for describing hydrodynamic/thermal fluctuations is by expressing them in the form of Extended Poisson-Kac Processes possessing prescribed correlation properties and a continuous velocity density function. We further highlight the importance of higher-order correlation functions in the description of the stochastic hydrodynamic velocity field with special reference to short-time properties of Brownian motion. We conclude by outlining some practical implications in connection with the statistical description of particle motion in confined geometries., Comment: 36 pages, 7 figures

Published
2023

9. Another normality is possible. Distributive transformations and emergent Gaussianity

Author

Giona, Massimiliano, Pezzotti, Chiara, and Procopio, Giuseppe

Subjects
Condensed Matter - Statistical Mechanics
Abstract

A distributional route to Gaussianity, associated with the concept of Conservative Mixing Transformations in ensembles of random vector-valued variables, is proposed. This route is completely different from the additive mechanism characterizing the application of Central Limit Theorem, as it is based on the iteration of a random transformation preserving the ensemble variance. Gaussianity emerges as a ``supergeneric'' property of ensemble statistics, in the case the energy constraint is quadratic in the norm of the variables. This result puts in a different light the occurrence of equilibrium Gaussian distributions in kinetic variables (velocity, momentum), as it shows mathematically that, in the absence of any other dynamic mechanisms, almost Gaussian distributions stems from the low-velocity approximations of the physical conservation principles. Whenever, the energy constraint is not expressed in terms of quadratic functions (as in the relativistic case), the Juttner distribution is recovered from CMT.

Published
2023

10. Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Author

Massari, Francesco, Santoni, Matteo, Takeshita, Hideki, Okada, Yohei, Tapia, Jose Carlos, Basso, Umberto, Maruzzo, Marco, Scagliarini, Sarah, Büttner, Thomas, Fornarini, Giuseppe, Myint, Zin W., Galli, Luca, Souza, Vinicius Carrera, Pichler, Renate, De Giorgi, Ugo, Gandur, Nathalia, Lam, Elaine T., Gilbert, Danielle, Popovic, Lazar, Grande, Enrique, Mammone, Giulia, Berardi, Rossana, Crabb, Simon J., Kemp, Robert, Molina-Cerrillo, Javier, Freitas, Marcelo, Luz, Murilo, Iacovelli, Roberto, Calabrò, Fabio, Tural, Deniz, Atzori, Francesco, Küronya, Zsófia, Chiari, Rita, Campos, Saul, Caffo, Orazio, Fay, André P., Kucharz, Jakub, Zucali, Paolo Andrea, Rinck, José Augusto, Zeppellini, Annalisa, Bastos, Diogo Assed, Aurilio, Gaetano, Mota, Augusto, Trindade, Karine, Ortega, Cinzia, Sade, Juan Pablo, Rizzo, Mimma, Fiala, Ondřej, Vau, Nuno, Giannatempo, Patrizia, Barillas, Allan, Monteiro, Fernando Sabino M., Dauster, Breno, Mennitto, Alessia, Nogueira, Lucas, de Carvalho Fernandes, Roni, Seront, Emmanuel, Aceituno, Luís Garcia, Grillone, Francesco, Cutuli, Hernan Javier, Fernandez, Mauricio, Bassanelli, Maria, Kopp, Ray Manneh, Roviello, Giandomenico, Abahssain, Halima, Procopio, Giuseppe, Milella, Michele, Kopecky, Jindrich, Martignetti, Angelo, Messina, Carlo, Caitano, Manuel, Inman, Eva, Kanesvaran, Ravindran, Herchhorn, Daniel, Santini, Daniele, Bamias, Aristotelis, Bisonni, Renato, Mosca, Alessandra, Morelli, Franco, Maluf, Fernando, Soares, Andrey, Nunes, Fernando, Pinto, Alvaro, Zgura, Anca, Incorvaia, Lorena, Ansari, Jawaher, Zabalza, Ignacio Ortego, Landmesser, Johannes, Rizzo, Alessandro, Mollica, Veronica, Marchetti, Andrea, Rosellini, Matteo, Sorgentoni, Giulia, Battelli, Nicola, Buti, Sebastiano, Porta, Camillo, and Bellmunt, Joaquim

Published
2024
Full Text
View/download PDF

11. Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Author

Fiala, Ondřej, Buti, Sebastiano, Takeshita, Hideki, Okada, Yohei, Massari, Francesco, Palacios, Georgia Anguera, Dionese, Michele, Scagliarini, Sarah, Büttner, Thomas, Fornarini, Giuseppe, Myint, Zin W., Galli, Luca, Souza, Vinicius Carrera, Pichler, Renate, De Giorgi, Ugo, Quiroga, María Natalia Gandur, Gilbert, Danielle, Popovic, Lazar, Grande, Enrique, Mammone, Giulia, Berardi, Rossana, Crabb, Simon J., Molina-Cerrillo, Javier, Freitas, Marcelo, Luz, Murilo, Iacovelli, Roberto, Calabrò, Fabio, Tural, Deniz, Atzori, Francesco, Küronya, Zsófia, Chiari, Rita, Campos, Saul, Caffo, Orazio, Fay, André P., Kucharz, Jakub, Zucali, Paolo Andrea, Rinck, José Augusto, Zeppellini, Annalisa, Bastos, Diogo Assed, Aurilio, Gaetano, Mota, Augusto, Trindade, Karine, Ortega, Cinzia, Sade, Juan Pablo, Rizzo, Mimma, Vau, Nuno, Giannatempo, Patrizia, Barillas, Allan, Monteiro, Fernando Sabino Marques, Dauster, Breno, Cattrini, Carlo, Nogueira, Lucas, de Carvalho Fernandes, Roni, Seront, Emmanuel, Aceituno, Luís Garcia, Grillone, Francesco, Cutuli, Hernan Javier, Fernandez, Mauricio, Bassanelli, Maria, Roviello, Giandomenico, Abahssain, Halima, Procopio, Giuseppe, Milella, Michele, Kopecky, Jindrich, Martignetti, Angelo, Messina, Carlo, Caitano, Manuel, Inman, Eva, Kanesvaran, Ravindran, Herchenhorn, Daniel, Santini, Daniele, Manneh, Ray, Bisonni, Renato, Zakopoulou, Roubini, Mosca, Alessandra, Morelli, Franco, Maluf, Fernando, Soares, Andrey, Nunes, Fernando, Pinto, Alvaro, Zgura, Anca, Incorvaia, Lorena, Ansari, Jawaher, Zabalza, Ignacio Ortego, Landmesser, Johannes, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Battelli, Nicola, Porta, Camillo, Bellmunt, Joaquim, and Santoni, Matteo

Published
2023
Full Text
View/download PDF

12. Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial

Author

Nasca, Vincenzo, Prinzi, Natalie, Coppa, Jorgelina, Prisciandaro, Michele, Oldani, Simone, Ghelardi, Filippo, Conca, Elena, Capone, Iolanda, Busico, Adele, Perrone, Federica, Tamborini, Elena, Sabella, Giovanna, Greco, Giorgio, Greco, Francesca Gabriella, Tafuto, Salvatore, Procopio, Giuseppe, Morano, Federica, Niger, Monica, Maccauro, Marco, Milione, Massimo, de Braud, Filippo, Pietrantonio, Filippo, and Pusceddu, Sara

Published
2024
Full Text
View/download PDF

13. Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies

Author

Altavilla, Amelia, Atzori, Francesco, Banna, Giuseppe Luigi, Barni, Sandro, Basso, Umberto, Bauckneht, Matteo, Berardi, Rossana, Berruti, Alfredo, Bertoldo, Francesco, Bimbatti, Davide, Boccardo, Francesco, Buti, Sebastiano, Buttigliero, Consuelo, Caffo, Orazio, Calabrò, Fabio, Cattrini, Carlo, Cellini, Francesco, Conteduca, Vincenza, Cursano, Maria Concetta, De Feo, Giulia, De Giorgi, Ugo, Di Lorenzo, Giuseppe, Di Maio, Massimo, Di Napoli, Marilena, Ermacora, Paola, Fornarini, Giuseppe, Fratino, Lucia, Fusco, Vittorio, Gernone, Angela, Ibrahim, Toni, Lanzetta, Gaetano, Malgeri, Andrea, Maruzzo, Marco, Masini, Cristina, Messina, Carlo, Mosca, Alessandra, Naglieri, Emanuele, Nolè, Franco, Ortega, Cinzia, Palermo, Andrea, Pantano, Francesco, Prati, Veronica, Procopio, Giuseppe, Rescigno, Pasquale, Roberto, Michela, Rossetti, Sabrina, Roviello, Giandomenico, Santini, Daniele, Stellato, Marco, Tambaro, Rosa, Toma, Ilaria, Tucci, Marcello, Valsecchi, Anna Amela, Verzoni, Elena, Zanardi, Elisa, Zucali, Paolo Andrea, Cursano, M.C., Valsecchi, A.A., Pantano, F., Di Maio, M., Procopio, G., Berruti, A., Bertoldo, F., Tucci, M., De Giorgi, U., and Santini, D.

Published
2024
Full Text
View/download PDF

14. Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Author

Santoni, Matteo, Massari, Francesco, Myint, Zin W., Iacovelli, Roberto, Pichler, Martin, Basso, Umberto, Kopecky, Jindrich, Kucharz, Jakub, Buti, Sebastiano, Rizzo, Mimma, Galli, Luca, Büttner, Thomas, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Zucali, Paolo Andrea, Fornarini, Giuseppe, Bourlon, Maria T., Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, Matrana, Marc R., Pichler, Renate, Cattrini, Carlo, Büchler, Tomas, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristotelis, Caffo, Orazio, Procopio, Giuseppe, Bassanelli, Maria, Merler, Sara, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Vau, Nuno, Incorvaia, Lorena, Rebuzzi, Sara Elena, Roviello, Giandomenico, Zabalza, Ignacio Ortego, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Monteiro, Fernando Sabino M., Montironi, Rodolfo, Battelli, Nicola, and Porta, Camillo

Published
2023
Full Text
View/download PDF

15. Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study

Author

Fotia, Giuseppe, Saieva, Calogero, Lee-Ying, Richard, Patrikidou, Anna, Nuzzo, Pier Vitale, Zanardi, Elisa, Rossetti, Sabrina, Davidsohn, Matthew, Eid, Marc, El Zarif, Talal, McClure, Heather, Spinelli, Gian Paolo, Damassi, Alessandra, Murianni, Veronica, Vauchier, Charles, Oliveira, Thiago Martins, Malgeri, Andrea, Modesti, Mikol, Mestre, Ricardo Pereira, Valenca, Loana, Ravi, Praful, Santini, Daniele, Pignata, Sandro, De Giorgi, Ugo, Sweeney, Christopher, Heng, Daniel, Procopio, Giuseppe, Russo, Antonio, and Francini, Edoardo

Published
2024
Full Text
View/download PDF

16. Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney

Author

Giudice, Giulia Claire, Maruzzo, Marco, Verzoni, Elena, Procopio, Giuseppe, Bimbatti, Davide, Sepe, Pierangela, Maines, Francesca, Grillone, Francesco, Cavo, Alessia, Santoni, Matteo, Cordua, Nadia, Pecoraro, Giovanna, Prati, Veronica, Napoli, Marilena Di, Ollari, Eli, Caruso, Giuseppe, Simoni, Nicola, Campobasso, Davide, and Buti, Sebastiano

Published
2024
Full Text
View/download PDF

17. Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27

Author

Stellato, Marco, Buti, Sebastiano, Maruzzo, Marco, Bassanelli, Maria, Bersanelli, Melissa, Napoli, Marilena Di, Dionese, Michele, Fanelli, Martina, Filippi, Roberto, Fotia, Giuseppe, Galli, Luca, Grillone, Francesco, Maffezzoli, Michele, Maiorano, Brigida Anna, Nasso, Cecilia, Rebuzzi, Sara Elena, Lalli, Luca, Roviello, Giandomenico, Sorarù, Mariella, Vincenzi, Bruno, Procopio, Giuseppe, and Verzoni, Elena

Published
2024
Full Text
View/download PDF

18. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology

Author

Marvaso, Giulia, Jereczek-Fossa, Barbara Alicja, Zaffaroni, Mattia, Vincini, Maria Giulia, Corrao, Giulia, Andratschke, Nicolaus, Balagamwala, Ehsan H, Bedke, Jens, Blanck, Oliver, Capitanio, Umberto, Correa, Rohann J M, De Meerleer, Gert, Franzese, Ciro, Gaeta, Aurora, Gandini, Sara, Garibaldi, Cristina, Gerszten, Peter C, Gillessen, Silke, Grubb, William R, Guckenberger, Matthias, Hannan, Raquibul, Jhaveri, Pavan M, Josipovic, Mirjana, Kerkmeijer, Linda G W, Lehrer, Eric J, Lindskog, Magnus, Louie, Alexander V, Nguyen, Quynh-Nhu, Ost, Piet, Palma, David A, Procopio, Giuseppe, Rossi, Maddalena, Staehler, Michael, Tree, Alison C, Tsang, Yat Man, Van As, Nicholas, Zaorsky, Nicholas G, Zilli, Thomas, Pasquier, David, and Siva, Shankar

Published
2024
Full Text
View/download PDF

20. Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9)

Author

Damassi, Alessandra, Cremante, Malvina, Signori, Alessio, Rebuzzi, Sara Elena, Fornarini, Giuseppe, Giudice, Giulia Claire, Maruzzo, Marco, Procopio, Giuseppe, Sorarù, Mariella, Di Napoli, Marilena, Fratino, Lucia, Santini, Daniele, Grillone, Francesco, Ballestrin, Melissa, Dionese, Michele, Nasso, Cecilia, Catalano, Fabio, Murianni, Veronica, Rescigno, Pasquale, Anpalakhan, Shobana, Banna, Giuseppe Luigi, Basso, Umberto, and Buti, Sebastiano

Published
2024
Full Text
View/download PDF

21. Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

Author

Nuzzo, Pier Vitale, Pederzoli, Filippo, Saieva, Calogero, Zanardi, Elisa, Fotia, Giuseppe, Malgeri, Andrea, Rossetti, Sabrina, Valenca Bueno, Loana, Andrade, Livia Maria Q. S., Patrikidou, Anna, Mestre, Ricardo Pereira, Modesti, Mikol, Pignata, Sandro, Procopio, Giuseppe, Fornarini, Giuseppe, De Giorgi, Ugo, Russo, Antonio, and Francini, Edoardo

Published
2023
Full Text
View/download PDF

24. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Author

Santoni, Matteo, Buti, Sebastiano, Myint, Zin W., Maruzzo, Marco, Iacovelli, Roberto, Pichler, Martin, Kopecky, Jindrich, Kucharz, Jakub, Rizzo, Mimma, Galli, Luca, Büttner, Thomas, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Zucali, Paolo Andrea, Kopp, Ray Manneh, Fornarini, Giuseppe, Bourlon, Maria T., Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, Matrana, Marc R., Pichler, Renate, Cattrini, Carlo, Büchler, Tomas, Massari, Francesco, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristotelis, Caffo, Orazio, Procopio, Giuseppe, Sunela, Kaisa, Bassanelli, Maria, Ortega, Cinzia, Grillone, Francesco, Landmesser, Johannes, Milella, Michele, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Santini, Daniele, Vau, Nuno, Morelli, Franco, Incorvaia, Lorena, Rebuzzi, Sara Elena, Roviello, Giandomenico, Soares, Andrey, Bisonni, Renato, Bimbatti, Davide, Zabalza, Ignacio Ortego, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, Monteiro, Fernando Sabino M., Battelli, Nicola, Bracarda, Sergio, and Porta, Camillo

Published
2024
Full Text
View/download PDF

26. Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

Author

Iacovelli, Roberto, Ciccarese, Chiara, Buti, Sebastiano, Zucali, Paolo Andrea, Fantinel, Emanuela, Bimbatti, Davide, Verzoni, Elena, Accettura, Caterina, Bonomi, Lucia, Buttigliero, Consuelo, Fornarini, Giuseppe, Pipitone, Stefania, Atzori, Francesco, Masini, Cristina, Massari, Francesco, Primi, Francesca, Strusi, Alessandro, Giudice, Giulia Claire, Perrino, Matteo, Maruzzo, Marco, Milella, Michele, Giannarelli, Diana, Brunelli, Matteo, Procopio, Giuseppe, and Tortora, Giampaolo

Published
2024
Full Text
View/download PDF

29. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

Author

Saad, Fred, Clarke, Noel W, Oya, Mototsugu, Shore, Neal, Procopio, Giuseppe, Guedes, João Daniel, Arslan, Cagatay, Mehra, Niven, Parnis, Francis, Brown, Emma, Schlürmann, Friederike, Joung, Jae Young, Sugimoto, Mikio, Sartor, Oliver, Liu, Yu-Zhen, Poehlein, Christian, Barker, Laura, del Rosario, Paula Michelle, and Armstrong, Andrew J

Published
2023
Full Text
View/download PDF

30. Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study

Author

Grünwald, Viktor, Powles, Thomas, Kopyltsov, Evgeny, Kozlov, Vadim, Alonso-Gordoa, Teresa, Eto, Masatoshi, Hutson, Thomas, Motzer, Robert, Winquist, Eric, Maroto, Pablo, Keam, Bhumsuk, Procopio, Giuseppe, Wong, Shirley, Melichar, Bohuslav, Rolland, Frederic, Oya, Mototsugu, Rodriguez-Lopez, Karla, Saito, Kenichi, McKenzie, Jodi, and Porta, Camillo

Published
2023
Full Text
View/download PDF

31. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Author

Pal, Sumanta Kumar, Albiges, Laurence, Tomczak, Piotr, Suárez, Cristina, Voss, Martin H, de Velasco, Guillermo, Chahoud, Jad, Mochalova, Anastasia, Procopio, Giuseppe, Mahammedi, Hakim, Zengerling, Friedemann, Kim, Chan, Osawa, Takahiro, Angel, Martín, Gupta, Suyasha, Khan, Omara, Bergthold, Guillaume, Liu, Bo, Kalaitzidou, Melania, Huseni, Mahrukh, Scheffold, Christian, Powles, Thomas, and Choueiri, Toni K

Published
2023
Full Text
View/download PDF

34. Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial

Author

Vignani, Francesca, Tambaro, Rosa, De Giorgi, Ugo, Giannatempo, Patrizia, Bimbatti, Davide, Carella, Claudia, Stellato, Marco, Atzori, Francesco, Aieta, Michele, Masini, Cristina, Hamzaj, Alketa, Ermacora, Paola, Veccia, Antonello, Scandurra, Giuseppa, Gamba, Teresa, Ignazzi, Gianluca, Pignata, Sandro, Di Napoli, Marilena, Lolli, Cristian, Procopio, Giuseppe, Pierantoni, Francesco, Zonno, Antonia, Santini, Daniele, and Di Maio, Massimo

Published
2023
Full Text
View/download PDF

37. SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM)

Author

Orlacchio, Antonio, Guastoni, Carlo, Beretta, Giordano Domenico, Cosmai, Laura, Galluzzo, Michele, Gori, Stefania, Grassedonio, Emanuele, Incorvaia, Lorena, Marcantoni, Carmelita, Netti, Giuseppe Stefano, Passamonti, Matteo, Porta, Camillo, Procopio, Giuseppe, Rizzo, Mimma, Roma, Silvia, Romanini, Laura, Stacul, Fulvio, and Casinelli, Alice

Published
2022
Full Text
View/download PDF

39. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

Author

Pal, Sumanta Kumar, Uzzo, Robert, Karam, Jose Antonio, Master, Viraj A, Donskov, Frede, Suarez, Cristina, Albiges, Laurence, Rini, Brian, Tomita, Yoshihiko, Kann, Ariel Galapo, Procopio, Giuseppe, Massari, Francesco, Zibelman, Matthew, Antonyan, Igor, Huseni, Mahrukh, Basu, Debasmita, Ci, Bo, Leung, William, Khan, Omara, Dubey, Sarita, and Bex, Axel

Published
2022
Full Text
View/download PDF

40. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Author

Schmidinger, Manuela, Bamias, Aristotelis, Procopio, Giuseppe, Hawkins, Robert, Sanchez, Angel Rodriguez, Vázquez, Sergio, Srihari, Narayanan, Kalofonos, Haralabos, Bono, Petri, Pisal, Chaitali Babanrao, Hirschberg, Yulia, Dezzani, Luca, Ahmad, Qasim, Jonasch, Eric, and Group, on behalf of the PRINCIPAL Study

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Kidney Disease, Cancer, Patient Safety, Clinical Research, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Evaluation of treatments and therapeutic interventions, Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Carcinoma, Renal Cell, Female, Follow-Up Studies, Humans, Indazoles, Kidney Neoplasms, Male, Middle Aged, Prognosis, Prospective Studies, Pyrimidines, Quality of Life, Sulfonamides, Survival Rate, Treatment Outcome, Young Adult, PRINCIPAL Study Group, Observational, Pazopanib, Real‐world, Renal cell carcinoma, Tyrosine kinase inhibitor, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BackgroundReal-world data are essential to accurately assessing efficacy and toxicity of approved agents in everyday practice. PRINCIPAL, a prospective, observational study, was designed to confirm the real-world safety and efficacy of pazopanib in patients with advanced renal cell carcinoma (RCC).Subjects, materials, and methodsPatients with clear cell advanced/metastatic RCC and a clinical decision to initiate pazopanib treatment within 30 days of enrollment were eligible. Primary objectives included progression-free survival (PFS), overall survival (OS), objective response rate (ORR), relative dose intensity (RDI) and its effect on treatment outcomes, change in health-related quality of life (HRQoL), and safety. We also compared characteristics and outcomes of clinical-trial-eligible (CTE) patients, defined using COMPARZ trial eligibility criteria, with those of non-clinical-trial-eligible (NCTE) patients. Secondary study objectives were to evaluate clinical efficacy, safety, and RDI in patient subgroups.ResultsSix hundred fifty-seven patients were enrolled and received ≥1 dose of pazopanib. Median PFS and OS were 10.3 months (95% confidence interval [CI], 9.2-12.0) and 29.9 months (95% CI, 24.7 to not reached), respectively, and the ORR was 30.3%. HRQoL showed no or little deterioration over time. Treatment-related serious adverse events (AEs) and AEs of special interest occurred in 64 (9.7%), and 399 (60.7%) patients, respectively. More patients were classified NCTE than CTE (85.2% vs. 14.8%). Efficacy of pazopanib was similar between the two groups.ConclusionPRINCIPAL confirms the efficacy and safety of pazopanib in patients with advanced/metastatic RCC in a real-world clinical setting.Implications for practicePRINCIPAL is the largest (n = 657) prospective, observational study of pazopanib in patients with advanced/metastatic renal cell carcinoma, to the authors' knowledge. Consistent with clinical trial results that often contain specific patient types, the PRINCIPAL study demonstrated that the effectiveness and safety of pazopanib is similarly safe and effective in patients with advanced kidney cancer in a real-world clinical setting. The PRINCIPAL study showed that patients with advanced kidney cancer who are treated with first-line pazopanib generally do not show disease progression for approximately 10 months and generally survive for nearly 30 months.

Published
2019

41. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Author

Tomczak, Piotr, Choueiri, Toni, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas R., Hajek, Jaroslav, Lin, Tzu-Ping, Symeonides, Stefan N., Lee, Jae Lyun, Sawrycki, Piotr, Haas, Naomi B., Gurney, Howard P., Mahave, Mauricio, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Chevreau, Christine, Burke, John M., Doshi, Gurjyot, Melichar, Bohuslav, Topart, Delphine, Oudard, Stephane, Kopyltsov, Evgeniy, Hammers, Hans-Joerg, Quinn, David I., Alva, Ajjai, Menezes, Juliana de Janoski, Silva, Adriano Goncalves e, Winquist, Eric W., Hamzaj, Alketa, Procopio, Giuseppe, Karaszewska, Boguslawa, Nowakowska-Zajdel, Ewa M., Alekseev, Boris Y., Gafanov, Rustem A., Izmailov, Adel, Semenov, Andrey, Afanasyev, Sergey G., Lipatov, Oleg N., Powles, Thomas B., Srinivas, Sandy, McDermott, David, Kochuparambil, Samith T., Davis, Ian D., Peltola, Katriina, Sabbatini, Roberto, Chung, Jinsoo, Shkolnik, Michail I., Matveev, Vsevolod B., Gajate Borau, Pablo, McCune, Steven, Hutson, Thomas E., Dri, Alejandro, Sales, Silvio Correia, Yeung, Carrie, Alcala Castro, Carmen Marcela, Bostrom, Peter, Laguerre, Brigitte, Buttigliero, Consuelo, de Giorgi, Ugo, Fomin, Eugeniy A., Zakharia, Yousef, Hwang, Clara, Singer, Eric A., Yorio, Jeffrey T., Waterhouse, David, Kowalyszyn, Ruben Dario, Alfie, Margarita Sonia, Yanez Ruiz, Eduardo, Buchler, Tomas, Kankaanranta, Krista, Ferretti, Gianluigi, Kimura, Go, Nishimura, Kazuo, Masumori, Naoya, Tamada, Satoshi, Kato, Haruaki, Kitamura, Hiroshi, Danielewicz, Iwona, Wojcik-Tomaszewska, Joanna, Sala Gonzalez, Nuria, Chiu, Kun-Yuan, Atkins, Michael B., Heath, Elisabeth, Rojas-Uribe, Gustavo Adolfo, Gonzalez Fernandez, Manuel Enrique, Feyerabend, Susan, Pignata, Sandro, Numakura, Kazuyuki, Cybulska Stopa, Bozena, Zukov, Ruslan, Climent Duran, Miguel Angel, Maroto Rey, Pablo Jose, Montesa Pino, Alvaro, Chang, Chao-Hsiang, Vengalil, Salil, Waddell, Tom S., Cobb, Patrick W., Hauke, Ralph, Anderson, Daniel M., Sarantopoulos, John, Gourdin, Theodore, Zhang, Tian, Jayram, Gautam, Fein, Luis Enrique, Harris, Carole, Beato, Patricia Medeiros Milhomem, Flores, Francisco, Estay, Angela, Rubiano, Juan Andres, Bedke, Jens, Hauser, Stefan, Neisius, Andreas, Busch, Jonas, Anai, Satoshi, Tsunemori, Hiroyuki, Sawka, Dariusz, Sikora-Kupis, Bozena, Arranz, Jose Angel, Delgado, Ignacio, Chen, Chung-Hsin, Gunderson, Elizabeth, Tykodi, Scott, Koletsky, Alan, Chen, Kevin, Agrawal, Manish, Kaen, Diego Lucas, Sade, Juan Pablo, Tatangelo, Marcelo Daniel, Parnis, Francis, Barbosa, Fernando Maciel, Faucher, Genevieve, Iqbal, Nayyer, Marceau, Daniele, Paradis, Jean-Benoit, Hanna, Nawar, Acevedo, Alejandro, Ibanez, Carolina, Villanueva, Luis, Galaz, Pedro Pablo, Durango, Isabel Cristina, Manneh, Ray, Kral, Zdenek, Holeckova, Petra, Hakkarainen, Heikki, Ronkainen, Hanna, Abadie-Lacourtoisie, Sophie, Tartas, Sophie, Goebell, Peter J., Grimm, Marc-Oliver, Hoefner, Thomas, Wirth, Manfred, Panic, Andrej, Schultze-Seemann, Wolfgang, Yokomizo, Akira, Mizuno, Ryuichi, Uemura, Hirotsugu, Eto, Masatoshi, Tsujihata, Masao, Matsukawa, Yoshihisa, Murakami, Yoji, Kim, Miso, Hamberg, Paul, Marczewska-Skrodzka, Malgorzata, Szczylik, Cezary, Humphreys, Alison C., Jiang, Peter, Kumar, Birendra, Lu, Gary, Desai, Arpita, Karam, Jose Antonio, Keogh, George, Fleming, Mark, Zarba, Juan Jose, Leiva, Viviana E., Mendez, Guillermo Ariel, Harris, Samuel J., Brown, Stephen J., Antonio Junior, Joao Neif, Costamilan, Rita de Cassia, Rocha, Roberto Odebrecht, Muniz, David, Brust, Leandro, Lalani, Aly-Khan, Graham, Jeffrey, Levesque, Michael, Orlandi, Francisco, Kotasek, Rostislav, Deville, Jean L., Borchiellini, Delphine, Merseburger, Axel, Rink, Michael, Roos, Frederik, McDermott, Ray, Oyama, Masafumi, Yamamoto, Yoshiaki, Tomita, Yoshihiko, Miura, Yuji, Ioritani, Naomasa, Westgeest, Hans, Kubiatowski, Tomasz, Bal, Wieslaw, Girones Sarrio, Regina, Rowe, Julie, Prow, Debra M., Senecal, Francis, Hashemi-Sadraei, Neda, Cole, Scott W., Kendall, Stephan D., Richards, Donald A., Schnadig, Ian D., Gupta, Mukul, Powles, Thomas, Ferguson, Thomas, Symeonides, Stefan N, Gurney, Howard, Chang, Yen-Hwa, Haas, Naomi B, Burgents, Joseph E, Xu, Lei, Imai, Kentaro, Quinn, David I, and Choueiri, Toni K

Published
2022
Full Text
View/download PDF

42. Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies

Author

Beretta, Giordano, Bella, Maria Angela, Bracarda, Sergio, Colombo, Nicoletta, Conteduca, Vincenza, Del Mastro, Lucia, Galvano, Antonio, Gristina, Valerio, Guarneri, Valentina, La Verde, Nicla, Lorusso, Domenica, Marchetti, Paolo, Normanno, Nicola, Ottini, Laura, Pensabene, Matilde, Pignata, Sandro, Procopio, Giuseppe, Ricevuto, Enrico, Silvestris, Nicola, Tassone, Pierfrancesco, Tucci, Marcello, Donato, Vittorio, Carrara, Silvia, Paiella, Salvatore, Gentilini, Oreste, Gunelli, Roberta, Nicolis, Fabrizio, Buttitta, Fiamma, Colecchia, Maurizio, Fassan, Matteo, Malapelle, Umberto, Marchetti, Antonio, Marchiò, Caterina, Scarpa, Aldo, Truini, Mauro, Zamboni, Giuseppe, Gion, Massimo, Trevisiol, Chiara, Gronchi, Alessandro, Danesi, Romano, Di Marco, Vito, Carrera, Paola, Ghiorzo, Paola, Pasini, Barbara, Varesco, Liliana, Artibani, Walter, Ludovico, Giuseppe, Campanella, Ornella, Vatrano, Simona, Tagliafico, Enrico, Russo, A., Incorvaia, L., Capoluongo, E., Tagliaferri, P., Gori, S., Cortesi, L., Genuardi, M., Turchetti, D., De Giorgi, U., Di Maio, M., Barberis, M., Dessena, M., Del Re, M., Lapini, A., Luchini, C., Jereczek-Fossa, B.A., Sapino, A., and Cinieri, S.

Published
2022
Full Text
View/download PDF

43. Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study

Author

Procopio, Giuseppe, Chiuri, Vincenzo, Mantini, Giovanna, Roberto Bordonaro, Roberto Maisano., Cinieri, Saverio, Rossetti, Sabrina, De Placido, Sabino, Airoldi, Mario, Galli, Luca, Gasparro, Donatello, Ludovico, Giuseppe Mario, Guglielmini, Pamela Francesca, Santini, Daniele, Naglieri, Emanuele, Fagnani, Daniele, Aglietta, Massimo, Livi, Lorenzo, Schips, Luigi, Passalacqua, Rodolfo, Fiore, Michele, D'Angelillo, Rolando Maria, Ceresoli, Giovanni Luca, Magrini, Stefano, Rondonotti, David, Mirone, Vincenzo, Ferriero, Maria Consiglia, Sciarra, Alessandro, Acquati, Mirko, Boccardo, Francesco, Scagliotti, Giorgio Vittorio, Mencoboni, Manlio, De Giorgi, Ugo, Micheletti, Gennaro, Lanzetta, Gaetano, Sartori, Donata, Carlini, Paolo, Soto Parra, Hector Josè, Battaglia, Michele, Uricchio, Francesco, Bernardo, Antonio, De Lisa, Antonello, Carrieri, Giuseppe, Ardizzoia, Antonio, Aieta, Michele, Pisconti, Salvatore, Marchetti, Paolo, Paiar, Fabiola, Procopio, G., Chiuri, V.E., Giordano, M., Alitto, A.R., Maisano, R., Bordonaro, R., Cinieri, S., Rossetti, S., De Placido, S., Airoldi, M., Galli, L., Gasparro, D., Ludovico, G.M., Guglielmini, P.F., Carella, C., Nova, P., Aglietta, M., Schips, L., Beccaglia, P., Sciarra, A., Livi, L., and Santini, D.

Published
2022
Full Text
View/download PDF

44. The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

Author

Rebuzzi, Sara Elena, Signori, Alessio, Banna, Giuseppe Luigi, Gandini, Annalice, Fornarini, Giuseppe, Damassi, Alessandra, Maruzzo, Marco, De Giorgi, Ugo, Basso, Umberto, Chiellino, Silvia, Galli, Luca, Zucali, Paolo Andrea, Fantinel, Emanuela, Naglieri, Emanuele, Procopio, Giuseppe, Milella, Michele, Boccardo, Francesco, Fratino, Lucia, Pipitone, Stefania, Ricotta, Riccardo, Panni, Stefano, Mollica, Veronica, Sorarù, Mariella, Santoni, Matteo, Cortellini, Alessio, Prati, Veronica, Soto Parra, Hector Josè, Santini, Daniele, Atzori, Francesco, Di Napoli, Marilena, Caffo, Orazio, Messina, Marco, Morelli, Franco, Prati, Giuseppe, Nolè, Franco, Vignani, Francesca, Cavo, Alessia, Roviello, Giandomenico, Rescigno, Pasquale, and Buti, Sebastiano

Published
2022
Full Text
View/download PDF

45. The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs

Author

Del Re, Marzia, Crucitta, Stefania, Paolieri, Federico, Cucchiara, Federico, Verzoni, Elena, Bloise, Francesco, Ciampi, Raffaele, Mercinelli, Chiara, Capuano, Annalisa, Sportiello, Liberata, Martinetti, Antonia, Procopio, Giuseppe, Galli, Luca, Porta, Camillo, Bracarda, Sergio, and Danesi, Romano

Published
2022
Full Text
View/download PDF

46. Prostate Cancer: Advanced and Metastatic Disease

Author

Iacovelli, Roberto, Ratta, Raffaele, Ciccarese, Chiara, Fantinel, Emanuela, Bimbatti, Davide, Verzoni, Elena, Procopio, Giuseppe, Riva Sanseverino, Eleonora, Editor-in-Chief, Amenta, Carlo, Series Editor, Carapezza, Marco, Series Editor, Chiodi, Marcello, Series Editor, Laghi, Andrea, Series Editor, Maresca, Bruno, Series Editor, Micale, Giorgio Domenico Maria, Series Editor, Mocciaro Li Destri, Arabella, Series Editor, Öchsner, Andreas, Series Editor, Piva, Mariacristina, Series Editor, Russo, Antonio, Series Editor, Seel, Norbert M., Series Editor, Peeters, Marc, editor, Incorvaia, Lorena, editor, and Rolfo, Christian, editor

Published
2021
Full Text
View/download PDF

47. Renal Cancer

Author

Incorvaia, Lorena, Procopio, Giuseppe, Porta, Camillo, Riva Sanseverino, Eleonora, Editor-in-Chief, Amenta, Carlo, Series Editor, Carapezza, Marco, Series Editor, Chiodi, Marcello, Series Editor, Laghi, Andrea, Series Editor, Maresca, Bruno, Series Editor, Micale, Giorgio Domenico Maria, Series Editor, Mocciaro Li Destri, Arabella, Series Editor, Öchsner, Andreas, Series Editor, Piva, Mariacristina, Series Editor, Russo, Antonio, Series Editor, Seel, Norbert M., Series Editor, Peeters, Marc, editor, Incorvaia, Lorena, editor, and Rolfo, Christian, editor

Published
2021
Full Text
View/download PDF

48. Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial

Author

Thiery-Vuillemin, Antoine, de Bono, Johann, Hussain, Maha, Roubaud, Guilhem, Procopio, Giuseppe, Shore, Neal, Fizazi, Karim, dos Anjos, Gabriel, Gravis, Gwenaelle, Joung, Jae Young, Matsubara, Nobuaki, Castellano, Daniel, Degboe, Arnold, Gresty, Chris, Kang, Jinyu, Allen, Allison, Poehlein, Christian, and Saad, Fred

Published
2022
Full Text
View/download PDF

49. Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication

Author

Buti, Sebastiano, Basso, Umberto, Giannarelli, Diana, De Giorgi, Ugo, Maruzzo, Marco, Iacovelli, Roberto, Galli, Luca, Porta, Camillo, Carrozza, Francesco, Procopio, Giuseppe, Fonarini, Giuseppe, Lo Re, Giovanni, Santoni, Matteo, Sabbatini, Roberto, Cusmai, Antonio, Zucali, Paolo Andrea, Aschele, Carlo, Baldini, Editta, Zafarana, Elena, Favaretto, Adolfo, Leo, Silvana, Hamzaj, Alketa, Mirabelli, Rosanna, Nole’, Franco, Zai, Silvia, Chini, Claudio, Masini, Cristina, Fatigoni, Sonia, Rocchi, Andrea, Tamburini, Emiliano, Cortellini, Alessio, and Bersanelli, Melissa

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results